Buffalo colostrum peptide mitigates Parkinson's disease pathophysiology through Cullin-3 inhibition

Bioorg Chem. 2024 Apr:145:107242. doi: 10.1016/j.bioorg.2024.107242. Epub 2024 Feb 25.

Abstract

Colostrum/Milk is a chief repertoire of antioxidant peptides. Nuclear factor-erythroid 2 related factor 2 (Nrf2) is a viable target for Parkinson's Disease (PD), as this pathway deduced to be impaired in PD. Cullin-3 is one of the crucial E3 ligase responsible for its regulation. The present study screened peptide libraries of buffalo colostrum & milk peptides for Cullin-3 inhibition, thus ensuing activation of Nrf2 to alleviate the molecular etiopathology in PD using the C. elegans as a model. The structure was modelled, binding sites analyzed and peptide-interactions analyzed by docking. Among the 55 sequences (≤1 kDa), the peptide SFVSEVPEL having the highest dock score (-16.919) was synthesized and evaluated for its effects on oxidative stress markers, antioxidant enzymes, neurochemical marker and Nrf2/Skn-1 levels. The lead peptide alleviated the oxidative pathophysiology and behavioural deficits associated with PD in C. elegans.

Keywords: Antioxidant; Bioactive peptide; Cullin-3; Keap-1-Nrf2; Neuroprotective; Parkinson’s disease.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Buffaloes / metabolism
  • Caenorhabditis elegans / metabolism
  • Colostrum / metabolism
  • Cullin Proteins / metabolism
  • Female
  • NF-E2-Related Factor 2 / metabolism
  • Neuroprotective Agents* / pharmacology
  • Oxidative Stress
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / metabolism
  • Peptides / metabolism
  • Peptides / pharmacology
  • Pregnancy

Substances

  • Antioxidants
  • Cullin Proteins
  • NF-E2-Related Factor 2
  • Peptides
  • Neuroprotective Agents